Latin America Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) – Industry Size, Share, Trends, Growth, Forecast (2026 to 2034)
Market Size, 2025
$1.81 BnMarket Estimate, 2026
$1.88 BnMarket Forecast, 2034
$2.49 BnCAGR, 2026–2034
3.58%| Category | Leading Segment (Position) | Fastest-Growing Segment |
|---|---|---|
| By Test Type | Autoantibody tests and antinuclear antibody (ANA) assays | Advanced multiplex immunoassays and specialized biomarker testing panels |
| By Disease Application | Systemic autoimmune disorders (including rheumatoid arthritis and systemic lupus erythematosus) | Localized autoimmune disease diagnostics (including thyroiditis and multiple sclerosis) |
| By End User | Hospitals and commercial diagnostic laboratories | Specialized research centres and clinical reference laboratories |
| By Country / Region | Brazil and Mexico (leading regional healthcare markets) | Emerging Latin American clinical diagnostic hubs (Argentina and Chile) |
Market Structure: Highly competitive Latin American autoimmune diagnostics landscape featuring major international diagnostics corporations, medical technology leaders, and specialized assay manufacturers competing intensely through technological integrations, product portfolio expansions, strategic mergers and acquisitions, and localized distribution networks.
Key Companies: Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics, SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics, BioMerieux, Beckman Coulter, Hemagen Diagnostics, Quest Diagnostics, Eli Lilly, and GlaxoSmithKline.
The Latin America Autoimmune Diagnostics Market is projected to grow from USD 1.81 billion in 2025 to USD 1.88 billion in 2026 and reach USD 2.49 billion by 2034, registering a CAGR of 3.58% during the forecast period from 2026 to 2034.
Autoimmune diseases are a hyperactive immune response against their own body tissues and cells. The introduction of advanced technologies through mergers & acquisitions into the market plays a key role in the cure and treatment of autoimmune diseases.
Increasing occurrence of autoimmune disorders, high disposable income, increasing public awareness, and improving healthcare infrastructure are the major factors driving the market's growth.
The key restraints that inhibit the autoimmune diagnostics market's growth are the high cost of treatment, unavailability of skilled labor, and the growing rate of diagnostics errors.
This research report is on the Latin America Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:
By Test Type:
By Disease Type:
By End User:
By Country:
Companies playing a notable role in the Latin America Autoimmune disease market profiled in this report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region